Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Szapary · SciRah

Researcher profile · Semantic Scholar

P. Szapary

Share profile

P. Szapary — researcher profile on SciRah

h-index: 45
Works: 116
Citations: 11K

Most-cited papers

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
K. Papp, R. Langley, M. Lebwohl, G. Krueger +8 more
2008The Lancet1,110 citations
Semantic Scholar
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
B. Sands, W. Sandborn, R. Panaccione, C. O'Brien +12 more
2019New England Journal of Medicine957 citations Open access
Semantic Scholar
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
M. Cuchel, L. Bloedon, P. Szapary, D. Kolansky +7 more
2007New England Journal of Medicine528 citations Open access
Semantic Scholar
Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis.
H. Sofen, Stacy Smith, R. Matheson, C. Leonardi +9 more
2014Journal of Allergy and Clinical Immunology304 citations Open access
Semantic Scholar
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
K. Gordon, K. Duffin, R. Bissonnette, J. Prinz +6 more
2015New England Journal of Medicine299 citations Open access
Semantic Scholar
Flaxseed and Cardiovascular Risk Factors: Results from a Double Blind, Randomized, Controlled Clinical Trial
L. Bloedon, Shilpa C. Balikai, J. Chittams, S. Cunnane +3 more
2008Journal of the American College of Nutrition255 citations
Semantic Scholar
Association of psychological and physiological measures of stress in health-care professionals during an 8-week mindfulness meditation program: mindfulness in practice
M. Galantino, M. Baime, M. Maguire, P. Szapary +1 more
2005237 citations
Semantic Scholar
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.
I. Landells, C. Marano, Ming-Chun Hsu, Shu Li +9 more
2015Journal of American Academy of Dermatology232 citations Open access
Semantic Scholar
Flaxseed and cardiovascular risk.
L. Bloedon, P. Szapary
2004Nutrition reviews231 citations
Semantic Scholar
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
O. Adedokun, Zhen-Hua Xu, C. Gasink, D. Jacobstein +8 more
2018Gastroenterology226 citations Open access
Semantic Scholar
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
R. Langley, S. Feldman, Cheng-Long Han, B. Schenkel +5 more
2010Journal of American Academy of Dermatology217 citations
Semantic Scholar
Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL).
T. Tsai, J. Ho, Michael Song, P. Szapary +7 more
2011Journal of dermatological science (Amsterdam)204 citations
Semantic Scholar
CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
M. Lehrke, Segan C. Millington, M. Lefterova, Reshmaal Gomes Cumaranatunge +5 more
2007Journal of the American College of Cardiology191 citations Open access
Semantic Scholar
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
P. Rutgeerts, C. Gasink, D. Chan, Ying-Hua Lang +9 more
2018Gastroenterology171 citations
Semantic Scholar
Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome
P. Szapary, L. Bloedon, F. Samaha, Danielle Duffy +5 more
2006Arteriosclerosis, Thrombosis and Vascular Biology160 citations Open access
Semantic Scholar
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials.
K. Gordon, K. Papp, R. Langley, V. Ho +8 more
2012Journal of American Academy of Dermatology139 citations
Semantic Scholar
Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome
F. Samaha, P. Szapary, N. Iqbal, Monica M Williams +4 more
2005Arteriosclerosis, Thrombosis and Vascular Biology138 citations Open access
Semantic Scholar
Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis.
A. Kimball, P. Szapary, U. Mrowietz, K. Reich +6 more
2012Journal of American Academy of Dermatology127 citations
Semantic Scholar
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
B. Ky, A. Burke, S. Tsimikas, M. Wolfe +5 more
2008Journal of the American College of Cardiology127 citations Open access
Semantic Scholar
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations.
M. Lebwohl, N. Yeilding, P. Szapary, Yu-Hua Wang +5 more
2010Journal of American Academy of Dermatology123 citations
Semantic Scholar
Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.
Catherine E. Ulbricht, E. Basch, P. Szapary, Paul G. Hammerness +6 more
2005Complementary Therapies in Medicine112 citations Open access
Semantic Scholar
Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study
B. Sands, W. Sandborn, B. Feagan, G. Lichtenstein +10 more
2018Journal of Crohn's & Colitis110 citations
Semantic Scholar
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials.
M. Lebwohl, C. Leonardi, C. Griffiths, J. Prinz +6 more
2012Journal of American Academy of Dermatology107 citations
Semantic Scholar
A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesity
G. Foster, Kerri Leh Shantz, S. V. Vander Veur, T. Oliver +6 more
2012American Journal of Clinical Nutrition101 citations Open access
Semantic Scholar
The triglyceride-high-density lipoprotein axis: an important target of therapy?
P. Szapary, D. Rader
2004American Heart Journal99 citations
Semantic Scholar
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis: Ustekinumab PK and exposure-response in UC.
O. Adedokun, Zhen-Hua Xu, C. Marano, C. O'Brien +10 more
2019Clinical Gastroenterology and Hepatology95 citations Open access
Semantic Scholar
Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS).
Xue-Jun Zhu, M. Zheng, Michael Song, Yaung-Kaung Shen +3 more
2013Journal of Drugs in Dermatology93 citations
Semantic Scholar
Ustekinumab: Lessons Learned from Targeting Interleukin‐12/23p40 in Immune‐Mediated Diseases
M. Elliott, J. Benson, M. Blank, C. Brodmerkel +3 more
2009Annals of the New York Academy of Sciences89 citations
Semantic Scholar
Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults
N. Iqbal, S. Cardillo, S. Volger, L. Bloedon +3 more
2009Metabolic Syndrome and Related Disorders83 citations Open access
Semantic Scholar
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis
Y. Zhuang, C. Calderon, Stanley J. Jr Marciniak, E. Bouman‐Thio +6 more
2016European Journal of Clinical Pharmacology82 citations
Semantic Scholar
Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration.
E. Basch, Steve Bent, J. Collins, Cynthia Dacey +7 more
2007Journal of the Society for Integrative Oncology82 citations
Semantic Scholar
Flaxseed Reduces Plasma Cholesterol Levels in Hypercholesterolemic Mouse Models
M. Pellizzon, J. Billheimer, L. Bloedon, P. Szapary +1 more
2007Journal of the American College of Nutrition79 citations
Semantic Scholar
An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up.
K. Reich, K. Papp, C. Griffiths, P. Szapary +6 more
2012Journal of Drugs in Dermatology76 citations
Semantic Scholar
Impact of ustekinumab on health‐related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials
L. Guenther, C. Han, P. Szapary, B. Schenkel +4 more
2011Journal of the European Academy of Dermatology and Venereology74 citations
Semantic Scholar
Development of the IL‐12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives – an update
N. Yeilding, P. Szapary, C. Brodmerkel, J. Benson +7 more
2012Annals of the New York Academy of Sciences62 citations
Semantic Scholar
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.
C. Brodmerkel, E. Wadman, R. Langley, K. Papp +10 more
2013Journal of Drugs in Dermatology60 citations
Semantic Scholar
Development of the IL‐12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives
N. Yeilding, P. Szapary, C. Brodmerkel, J. Benson +7 more
2011Annals of the New York Academy of Sciences59 citations
Semantic Scholar
HLA-C*06:02 Allele and Response to IL-12/23 Inhibition: Results from the Ustekinumab Phase 3 Psoriasis Program.
Katherine Li, C. C. Huang, B. Randazzo, Shu Li +4 more
2016Journal of Investigative Dermatology56 citations Open access
Semantic Scholar
Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2
K. Reich, B. Schenkel, N. Zhao, P. Szapary +4 more
2011Journal of dermatological treatment (Print)50 citations
Semantic Scholar
Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis
N. Mehta, Katherine Li, P. Szapary, J. Krueger +1 more
2013Journal of Translational Medicine47 citations Open access
Semantic Scholar
Reversible posterior leukoencephalopathy syndrome in a patient treated with ustekinumab: case report and review of the literature.
D. Gratton, P. Szapary, K. Goyal, S. Fakharzadeh +2 more
2011Archives of Dermatology46 citations
Semantic Scholar
Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure–response modeling of physician’s global assessment score for ustekinumab in patients with psoriasis
Chuan-Pu Hu, P. Szapary, N. Yeilding, Hong-Hui Zhou
2011Journal of Pharmacokinetics and Pharmacodynamics40 citations
Semantic Scholar
Antidiabetic Action of Bezafibrate in a Large Observational Database
J. Flory, S. Ellenberg, P. Szapary, B. Strom +1 more
2009Diabetes Care37 citations Open access
Semantic Scholar
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
R. Bissonnette, F. Kerdel, L. Naldi, K. Papp +8 more
2017Journal of Drugs in Dermatology30 citations
Semantic Scholar
Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis
S. Martin, S. Feldman, M. Augustin, P. Szapary +1 more
2011Journal of dermatological treatment (Print)28 citations
Semantic Scholar
The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn’s Disease
B. Sands, Cheng-Long Han, C. Gasink, D. Jacobstein +6 more
2018Journal of Crohn's & Colitis27 citations Open access
Semantic Scholar
The new definition of myocardial infarction.
C. E. Guerra, P. Szapary
2003Archives of Internal Medicine23 citations
Semantic Scholar
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
J. Luke, D. Davar, R. Andtbacka, N. Bhardwaj +22 more
2024Journal for ImmunoTherapy of Cancer21 citations Open access
Semantic Scholar
Guggulipid for the Treatment of Hypercholesterolemia
P. Szapary, M. Wolfe, L. Bloedon, A. Cucchiara +3 more
201721 citations
Semantic Scholar
Sa1934 Pharmacokinetics and Exposure-Response Relationships of Ustekinumab during IV Induction and SC Maintenance Treatment of Patients with Crohn's Disease with Ustekinumab: Results from the UNITI-1, UNITI-2, and IM-UNITI Studies
O. Adedokun, Zhen-Hua Xu, C. Gasink, P. Szapary +6 more
201619 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Rader×11
Invite
D. Rader — researcher profile on SciRah
N. Yeilding×9
Invite
N. Yeilding — researcher profile on SciRah
Ming-Chun Hsu×8
Invite
Ming-Chun Hsu — researcher profile on SciRah
Shu Li×8
Invite
Shu Li — researcher profile on SciRah

×8

Invite

L. Bloedon — researcher profile on SciRah

Invite

R. Langley — researcher profile on SciRah

Invite

K. Reich — researcher profile on SciRah

Invite

W. Sandborn — researcher profile on SciRah

C. Brodmerkel×7

Invite

C. Brodmerkel — researcher profile on SciRah

Invite

K. Papp — researcher profile on SciRah

Invite

C. Guzzo — researcher profile on SciRah

Invite

J. Johanns — researcher profile on SciRah